SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VARANI, Katia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 45.992
AS - Asia 26.126
EU - Europa 16.347
SA - Sud America 4.039
AF - Africa 551
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 27
AN - Antartide 1
Totale 93.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 45.005
SG - Singapore 9.306
CN - Cina 6.707
BR - Brasile 3.116
VN - Vietnam 3.027
DE - Germania 2.989
FI - Finlandia 2.929
IT - Italia 2.438
UA - Ucraina 2.390
HK - Hong Kong 2.145
TR - Turchia 1.934
GB - Regno Unito 1.484
FR - Francia 945
SE - Svezia 845
RU - Federazione Russa 755
JP - Giappone 632
BD - Bangladesh 537
IN - India 533
PL - Polonia 527
CA - Canada 481
MX - Messico 375
AR - Argentina 334
ID - Indonesia 247
NL - Olanda 237
ZA - Sudafrica 203
IQ - Iraq 187
ES - Italia 155
EC - Ecuador 148
BE - Belgio 126
CO - Colombia 126
PK - Pakistan 112
LT - Lituania 98
VE - Venezuela 96
UZ - Uzbekistan 90
MA - Marocco 85
SA - Arabia Saudita 81
AT - Austria 78
CZ - Repubblica Ceca 71
CL - Cile 69
MY - Malesia 67
PH - Filippine 67
AE - Emirati Arabi Uniti 66
TN - Tunisia 61
KE - Kenya 53
PY - Paraguay 52
JO - Giordania 43
AU - Australia 34
IL - Israele 33
UY - Uruguay 33
CH - Svizzera 32
EG - Egitto 32
KR - Corea 32
PE - Perù 31
IE - Irlanda 30
DZ - Algeria 29
NP - Nepal 29
BO - Bolivia 28
IR - Iran 26
AL - Albania 24
RO - Romania 24
AZ - Azerbaigian 22
TW - Taiwan 22
CR - Costa Rica 20
KZ - Kazakistan 19
PT - Portogallo 19
EU - Europa 18
JM - Giamaica 18
ET - Etiopia 17
HN - Honduras 17
TH - Thailandia 17
KG - Kirghizistan 15
LB - Libano 15
OM - Oman 15
BH - Bahrain 14
PS - Palestinian Territory 14
SY - Repubblica araba siriana 14
BG - Bulgaria 13
LV - Lettonia 13
RS - Serbia 13
DO - Repubblica Dominicana 12
HU - Ungheria 12
NO - Norvegia 12
BY - Bielorussia 11
GR - Grecia 11
HR - Croazia 11
MD - Moldavia 11
BA - Bosnia-Erzegovina 10
CI - Costa d'Avorio 10
SN - Senegal 10
TT - Trinidad e Tobago 10
AM - Armenia 9
GT - Guatemala 9
PA - Panama 9
AO - Angola 8
CG - Congo 8
NI - Nicaragua 8
NZ - Nuova Zelanda 8
QA - Qatar 8
SV - El Salvador 8
GE - Georgia 7
Totale 92.986
Salva come PNG Salva come JPEG
Città #
Singapore 6.020
Ashburn 4.833
Woodbridge 3.958
Fairfield 3.397
San Jose 2.911
Jacksonville 2.613
Chandler 2.500
Houston 2.455
Helsinki 2.234
Ann Arbor 2.135
Hong Kong 2.102
Beijing 2.012
Santa Clara 1.909
Dallas 1.502
Wilmington 1.428
Seattle 1.355
Cambridge 1.110
Ho Chi Minh City 988
Izmir 897
Los Angeles 798
Nanjing 786
Hanoi 702
Tokyo 603
New York 592
Princeton 586
Munich 527
Ferrara 519
Lauterbourg 486
Warsaw 482
Boardman 479
Milan 367
Shanghai 321
São Paulo 320
San Diego 310
Council Bluffs 273
Nanchang 251
Orem 240
Shenyang 236
Mexico City 227
London 201
Tianjin 191
Turku 188
Buffalo 186
Dearborn 179
Hefei 174
Bremen 167
Chicago 166
Frankfurt am Main 160
Changsha 158
Montreal 158
Falkenstein 153
Chennai 152
The Dalles 152
Hebei 148
Jakarta 144
Da Nang 143
Addison 140
Jiaxing 138
Brooklyn 136
Haiphong 128
Brussels 121
Toronto 120
Denver 118
Johannesburg 108
Atlanta 103
Manchester 101
Moscow 99
San Mateo 99
San Francisco 98
Stockholm 96
Jinan 95
Rio de Janeiro 94
Rome 94
Zhengzhou 93
Falls Church 90
Phoenix 87
Norwalk 85
Amsterdam 83
Kunming 82
Bologna 81
Dong Ket 81
Tashkent 80
Poplar 78
Baghdad 76
Guangzhou 76
Boston 73
Mountain View 70
Ankara 64
Biên Hòa 62
Philadelphia 60
Auburn Hills 59
Belo Horizonte 59
Düsseldorf 58
Orange 58
Hải Dương 56
Ningbo 55
Columbus 54
Mumbai 53
Washington 51
Nuremberg 49
Totale 62.045
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.095
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 410
Pharmacology of Adenosine Receptors: The State of the Art 397
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 360
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 313
A glance at adenosine receptors: Novel target for antitumor therapy 308
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 298
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 298
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 296
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 289
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 284
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 283
The A3 adenosine receptor: history and perspectives 281
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 276
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 276
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 275
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 273
Recettori e trasduzione del segnale 270
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 267
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 263
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 261
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 260
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 260
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 257
Recettori e trasduzione del segnale 256
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 256
Adenosine receptors and human melanoma 255
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 254
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 254
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 253
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 253
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 250
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 246
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 245
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 245
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 244
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 243
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 243
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 242
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 242
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 241
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 241
Ala scan analogues of HOE 140. Synthesis and biological activities 239
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 238
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 237
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 236
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 236
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 236
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 235
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 234
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 233
Comparison of prazosin, terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues 232
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 228
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 228
Adenosine signaling contributes to ethanol-induced fatty liver in mice 225
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 225
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 224
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 224
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 224
Adenosine receptor targeting in health and disease 223
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 222
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 222
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 221
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 219
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 219
van't Hoff Based Thermodynamics 219
Current status of A1 adenosine receptor allosteric enhancers 218
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 217
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 217
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 217
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 217
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 217
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 216
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 215
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 215
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 215
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 214
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 214
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 213
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 212
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 211
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 211
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 211
Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats 210
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 210
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 210
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 210
Agonists and antagonists: Molecular mechanisms and therapeutic applications 210
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 209
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 209
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 208
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 208
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 207
Pathological overproduction: the bad side of adenosine 207
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 207
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 206
4-Amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies 206
Adenosine and lymphocyte regulation 206
An evaluation of fMLP pocket dimensions and features using formyltetrapeptides 206
Totale 26.991
Salva come PNG Salva come JPEG
Categoria #
all - tutte 387.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.584
Totale 396.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 0 0 0 0 0 0 407
2021/20225.145 126 552 340 225 245 210 232 269 193 432 731 1.590
2022/20235.734 592 432 176 795 954 821 269 458 700 46 296 195
2023/20242.851 289 377 142 83 316 343 136 209 57 72 77 750
2024/202512.275 311 354 946 618 1.431 1.133 460 739 1.729 1.390 1.711 1.453
2025/202637.209 3.432 1.629 3.585 4.462 4.967 2.339 3.975 1.789 5.243 3.973 1.420 395
Totale 93.857